Evidence map›Paper›PMID 23108492›Full record

ArticleJournal of neurology2013

ATL1 and REEP1 mutations in hereditary and sporadic upper motor neuron syndromes.

S T de Bot, J H Veldink, S Vermeer, A R Mensenkamp, F Brugman, H Scheffer, L H van den Berg, H P H Kremer, E J Kamsteeg, B P van de Warrenburg

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Screening forFrontiers in neurology · 2020
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

S T de BotDepartment of Neurology, Radboud University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. ST.Bot@neuro.umcn.nl
J H Veldink
S Vermeer
A R Mensenkamp
F Brugman
H Scheffer
L H van den Berg
H P H Kremer
E J Kamsteeg
B P van de Warrenburg
Radboud University Medical Center · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NLUniversity Medical Center Groningen · NLZiekenhuis Rivierenland · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SPAST mutations are the most common cause of autosomal dominant hereditary spastic paraplegias (AD-HSPs), but many spastic paraplegia patients are found to carry no mutations in this gene. In order to assess the contribution of ATL1 and REEP1 in AD-HSP, we performed mutational analysis in 27 SPAST-negative AD-HSP families. We found three novel ATL1 mutations and one REEP1 mutation in five index-patients. In 110 patients with sporadic adult-onset upper motor neuron syndromes, a novel REEP1 mutation was identified in one patient. Apart from a significantly younger age at onset in ATL1 patients and restless legs in some, the clinical phenotype of ATL1 and REEP1 was similar to other pure AD-HSPs.

Indexed as

AdolescentAdultAgedCohort StudiesFemaleGTP-Binding ProteinsHumansMaleMembrane ProteinsMembrane Transport ProteinsMiddle AgedMotor Neuron DiseaseMutationPedigreeRetrospective StudiesYoung AdultATL1 protein, humanGTP-Binding ProteinsMembrane ProteinsMembrane Transport ProteinsREEP1 protein, human

Identifiers

PMID23108492
OpenAlexW2153441628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.